Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumours

Masuko Katoh; Izuma Nakayama; Zev A Wainberg; Kohei Shitara; Masaru Katoh

doi:10.1002/ctm2.1736

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (6) : e1736 DOI: 10.1002/ctm2.1736

COMMENTARY

Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumours

Author information +

History +

PDF

Cite this article

Download citation ▾

Masuko Katoh, Izuma Nakayama, Zev A Wainberg, Kohei Shitara, Masaru Katoh. Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumours. Clinical and Translational Medicine, 2024, 14(6): e1736 DOI:10.1002/ctm2.1736

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.